Outcome of written procedures finalised during the period from 12 March to 03 June 2024
Webinar for industry and contract research organisations (CROs) on revised Environmental Risk Assessment (ERA) guideline for human medicinal products, Online, European Medicines Agency, Amsterdam, the Netherlands, 26 June 2024
Overview of comments received on draft qualification opinion for Centiloid measure of Amyloid PET to quantify brain amyloid deposition
Qualification opinion for Centiloid measure of Amyloid PET to quantify brain amyloid deposition
Budesonide, prolonged release tablets, 9 mg product-specific bioequivalence guidance
Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 16, Status: Authorised
Contractor SOP/MLM - WIN/MLM
EVVet3 EVWeb Production – Release notes
First EMA-Animal Health Europe annual bilateral meeting , Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 July 2024, 13:30 (CEST) to 1 July 2024, 15:00 (CEST)
Agenda of the CHMP meeting 24-27 June 2024